REFERENCES
- Berrios G E, Beer D. Unitary psychosis concept. A history of clinical psychiatry, G E Berrios, R Porter. Athlone, London 1995; 313–35
- Angst J. Historical aspects of the dichotomy between manic-depressive disorders and schizophrenia. Schizophr Res 2002; 57: 5–13, [PUBMED], [INFOTRIEVE], [CSA]
- Psychiatry: a textbook for students and physicians6th ed., K E Kraepelin, J M Quen, H Metoul, S Ayed. Science History, Canton, MA 1990; vol. 1, (vol. 2), trans [third English (full) trans. of: Psychiatrie: Ein Lehrbuch für Studierende und Ärzte. (2 vols.). 1899]
- Kasanin J. The acute schizo-affective psychoses. Am J Psychiatry 1933; 90: 97–126, [CSA]
- Pope H G, Jr, Lipinski J F, Jr. Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of ‘schizophrenic’ symptoms in the light of current research. Arch Gen Psychiatry 1978; 35: 811–28, [PUBMED], [INFOTRIEVE], [CSA]
- Schwartz J E, Fennig S, Tanenberg-Karant M, et al. Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis. Arch Gen Psychiatry 2000; 57: 593–600, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Maj M, Pirozzi R, Formicola A M, Bartoli L, Bucci P. Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: preliminary data. J Affect Disord 2000; 57: 95–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Faraone S V, Blehar M, Pepple J, et al. Diagnostic accuracy and confusability analyses: an application to the Diagnostic Interview for Genetic Studies. Psychol Med 1996; 26: 401–10, [PUBMED], [INFOTRIEVE], [CSA]
- Kendler K S, Karkowski L M, Walsh D. The structure of psychosis: latent class analysis of probands from the Roscommon Family Study. Arch Gen Psychiatry 1998; 55: 492–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kupfer D J, First M B, Regier D E. Introduction. A research agenda for DSM-V, D J Kupfer, M B First, D E Regier. American Psychiatric Association, Washington, DC 2002; xv–xxiii
- McHugh P. Beyond DSM-IV: from appearances to essences. Psychiatr Res Rep Am Psychiatr Assoc 2001; 17: 2–15, [CSA]
- McHugh P R, Slavney P R. The perspectives of psychiatry2nd ed. Johns Hopkins University Press, Baltimore, MD 1998
- Gershon E S, Hamovit J, Guroff J J, et al. A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry 1982; 39: 1157–67, [PUBMED], [INFOTRIEVE], [CSA]
- Gershon E S, De Lisi L E, Hamovit J, et al. A controlled family study of chronic psychoses. Schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 1988; 45: 328–36, [PUBMED], [INFOTRIEVE], [CSA]
- Maier W, Lichtermann D, Minges J, et al. Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study. Arch Gen Psychiatry 1993; 50: 871–83, [PUBMED], [INFOTRIEVE], [CSA]
- Kendler K S, Gruenberg A M, Tsuang M T. Psychiatric illness in first-degree relatives of schizophrenic and surgical control patients. A family study using DSM-III criteria. Arch Gen Psychiatry 1985; 42: 770–9, [PUBMED], [INFOTRIEVE], [CSA]
- Kendler K S, Gruenberg A M, Tsuang M T. A DSM-III family study of the nonschizophrenic psychotic disorders. Am J Psychiatry 1986; 143: 1098–105, [PUBMED], [INFOTRIEVE], [CSA]
- Kendler K S, McGuire M, Gruenberg A M, O'Hare A, Spellman M, Walsh D. The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Arch Gen Psychiatry 1993; 50: 527–40, [PUBMED], [INFOTRIEVE], [CSA]
- Kendler K S, McGuire M, Gruenberg A M, O'Hare A, Spellman M, Walsh D. The Roscommon Family Study. IV. Affective illness, anxiety disorders, and alcoholism in relatives. Arch Gen Psychiatry 1993; 50: 952–60, [PUBMED], [INFOTRIEVE], [CSA]
- Erlenmeyer-Kimling L, Adamo U H, et al. The New York High-Risk Project. Prevalence and comorbidity of axis I disorders in offspring of schizophrenic parents at 25-year follow-up. Arch Gen Psychiatry 1997; 54: 1096–102, [PUBMED], [INFOTRIEVE], [CSA]
- Potash J B, Willour V L, Chiu Y -F, et al. The familial aggregation of psychotic symptoms in bipolar disorder pedigrees. Am J Psychiatry 2001; 158: 1258–64, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Potash J B, Chiu Y F, MacKinnon D F, et al. Familial aggregation of psychotic symptoms in a replication set of 69 bipolar disorder pedigrees. Am J Med Genet 2003; 160: 680–6, [CSA]
- O'Mahony E, Corvin A, O'Connell R, et al. Sibling pairs with affective disorders: resemblance of demographic and clinical features. Psychol Med 2002; 32: 55–61, [PUBMED], [INFOTRIEVE], [CSA]
- Schurhoff F, Szoke A, Meary A, et al. Familial aggregation of delusional proneness in schizophrenia and bipolar pedigrees. Am J Psychiatry 2003; 160: 1313–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Winokur G, Scharfetter C, Angst J. A family study of psychotic symptomatology in schizophrenia, schizoaffective disorder, unipolar depression, and bipolar disorder. Eur Arch Psychiatry Neurol Sci 1985; 234: 295–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wickham H, Walsh C, Asherson P, et al. Familiality of symptom dimensions in schizophrenia. Schizophr Res 2001; 47: 223–32, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Burke J G, Murphy B M, Bray J C, Walsh D, Kendler K S. Clinical similarities in siblings with schizophrenia. Am J Med Genet 1996; 67: 239–43, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kendler K S, Karkowski-Shuman L, O'Neill F A, Straub R E, MacLean C J, Walsh D. Resemblance of psychotic symptoms and syndromes in affected sibling pairs from the Irish Study of High-Density Schizophrenia Families: evidence for possible etiologic heterogeneity. Am J Psychiatry 1997; 154: 191–8, [PUBMED], [INFOTRIEVE], [CSA]
- DeLisi L E, Goldin L R, Maxwell M E, Kazuba D M, Gershon E S. Clinical features of illness in siblings with schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1987; 44: 891–6, [PUBMED], [INFOTRIEVE], [CSA]
- Cardno A G, Jones L A, Murphy K C, et al. Sibling pairs with schizophrenia or schizoaffective disorder: associations of subtypes, symptoms and demographic variables. Psychol Med 1998; 28: 815–23, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Smoller J W, Finn C T. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet 2003; 123: 48–58, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sullivan P F, Kendler K S, Neale M C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003; 60: 1187–92, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Dalby J T, Morgan D, Lee M L. Schizophrenia and mania in identical twin brothers. J Nerv Ment Dis 1986; 174: 304–8, [PUBMED], [INFOTRIEVE], [CSA]
- McGuffin P, Reveley A, Holland A. Identical triplets: non-identical psychosis?. Br J Psychiatry 1982; 140: 1–6, [PUBMED], [INFOTRIEVE], [CSA]
- Farmer A E, McGuffin P, Gottesman I I. Twin concordance for DSM-III schizophrenia. Scrutinizing the validity of the definition. Arch Gen Psychiatry 1987; 44: 634–41, [PUBMED], [INFOTRIEVE], [CSA]
- Cardno A G, Rijsdijk F V, Sham P C, Murray R M, McGuffin P. A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry 2002; 159: 539–45, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ferrier I N, Thompson J M. Cognitive impairment in bipolar affective disorder: implications for the bipolar diathesis. Br J Psychiatry 2002; 180: 293–5, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Erlenmeyer-Kimling L, Cornblatt B A. A summary of attentional findings in the New York High-Risk Project. J Psychiatr Res 1992; 26: 405–26, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gourovitch M L, Torrey E F, Gold J M, Randolph C, Weinberger D R, Goldberg T E. Neuropsychological performance of monozygotic twins discordant for bipolar disorder. Biol Psychiatry 1999; 45: 639–46, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Egan M F, Goldberg T E, Kolachana B S, et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001; 98: 6917–22, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cannon T D, Hennah W, van Erp T G, et al. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch Gen Psychiatry 2005; 62: 1205–13, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Siegel C, Waldo M, Mizner G, Adler L E, Freedman R. Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses. Arch Gen Psychiatry 1984; 41: 607–12, [PUBMED], [INFOTRIEVE], [CSA]
- Olincy A, Martin L. Diminished suppression of the P50 auditory evoked potential in bipolar disorder subjects with a history of psychosis. Am J Psychiatry 2005; 162: 43–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Leonard S, Gault J, Hopkins J, et al. Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry 2002; 59: 1085–96, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Blackwood D H, Fordyce A, Walker M T, St Clair D M, Porteous D J, Muir W J. Schizophrenia and affective disorders—cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet 2001; 69: 428–33, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lander E S, Linton L M, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860–921, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Roberts S B, MacLean C J, Neale M C, Eaves L J, Kendler K S. Replication of linkage studies of complex traits: an examination of variation in location estimates. Am J Hum Genet 1999; 65: 876–84, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Segurado R, Detera-Wadleigh S D, Levinson D F, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: bipolar disorder. Am J Hum Genet 2003; 73: 49–62, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lewis C M, Levinson D F, Wise L H, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet 2003; 73: 34–48, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Badner J A, Gershon E S. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 2002; 7: 405–11, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Blouin J L, Dombroski B A, Nath S K, et al. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 1998; 20: 70–3, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Berrettini W H. Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol Psychiatry 2000; 48: 531–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Potash J B, Zandi P P, Willour V L, et al. Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder. Am J Psychiatry 2003; 160: 680–6, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Park N, Juo S H, Cheng R, et al. Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia. Mol Psychiatry 2004; 9: 1091–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ophoff R A, Escamilla M A, Service S K, et al. Genomewide linkage disequilibrium mapping of severe bipolar disorder in a population isolate. Am J Hum Genet 2002; 71: 565–74, [PUBMED], [INFOTRIEVE], [CSA]
- Ekelund J, Hovatta I, Parker A, et al. Chromosome 1 loci in Finnish schizophrenia families. Hum Mol Genet 2001; 10: 1611–7, [PUBMED], [INFOTRIEVE], [CSA]
- Macgregor S, Visscher P M, Knott S A, et al. A genome scan and follow-up study identify a bipolar disorder susceptibility locus on chromosome 1q42. Mol Psychiatry 2004; 9: 1083–90, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Levinson D F, Holmans P, Straub R E, et al. Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. Am J Hum Genet 2000; 67: 652–63, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Middleton F A, Pato M T, Gentile K L, et al. Genomewide linkage analysis of bipolar disorder by use of a high-density single-nucleotide-polymorphism (SNP) genotyping assay: a comparison with microsatellite marker assays and finding of significant linkage to chromosome 6q22. Am J Hum Genet 2004; 74: 886–97, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Schulze T G, Buervenich S, Badner J A, et al. Loci on chromosomes 6q and 6p interact to increase susceptibility to bipolar affective disorder in the National Institute of Mental Health Genetics Initiative pedigrees. Biol Psychiatry 2004; 56: 18–23, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Turecki G, Grof P, Grof E, et al. Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium. Mol Psychiatry 2001; 6: 570–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Freedman R, Coon H, Myles-Worsley M, et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A 1997; 94: 587–92, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Leonard S, Gault J, Moore T, et al. Further investigation of a chromosome 15 locus in schizophrenia: analysis of affected sibpairs from the NIMH Genetics Initiative Am J Med Genet 1998; 81: 308–12, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Straub R E, MacLean C J, Martin R B, et al. A schizophrenia locus may be located in region 10p15–p11. Am J Med Genet 1998; 81: 296–301, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Foroud T, Castelluccio P F, Koller D L, et al. Suggestive evidence of a locus on chromosome 10p using the NIMH Genetics Initiative bipolar affective disorder pedigrees. Am J Med Genet 2000; 96: 18–23, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Berrettini W H, Ferraro T N, Goldin L R, et al. Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene. Proc Natl Acad Sci USA 1994; 91: 5918–21, [PUBMED], [INFOTRIEVE], [CSA]
- Schwab S G, Hallmayer J, Lerer B, et al. Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis. Am J Hum Genet 1998; 63: 1139–52, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pulver A E, Mulle J, Nestadt G, et al. Genetic heterogeneity in schizophrenia: stratification of genome scan data using co-segregating related phenotypes. Mol Psychiatry 2000; 5: 650–3, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Maziade M, Roy M A, Chagnon Y C, et al. Shared and specific susceptibility loci for schizophrenia and bipolar disorder: a dense genome scan in Eastern Quebec families. Mol Psychiatry 2005; 10: 486–99, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sklar P, Pato M T, Kirby A, et al. Genome-wide scan in Portuguese Island families identifies 5q31–q35 as a susceptibility locus for schizophrenia and psychosis. Mol Psychiatry 2004; 9: 213–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516–7, [see comments][PUBMED], [INFOTRIEVE], [CSA]
- Spielman R S, McGinnis R E, Ewens W J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506–16, [PUBMED], [INFOTRIEVE], [CSA]
- Risch N J. Searching for genetic determinants in the new millennium. Nature 2000; 405: 847–56, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Glatt S J, Faraone S V, Tsuang M T. Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia. Mol Psychiatry 2003; 8: 911–5, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Abdolmaleky H M, Faraone S V, Glatt S J, Tsuang M T. Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia. Schizophr Res 2004; 67: 53–62, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Fanous A H, Neale M C, Straub R, et al. Clinical features of psychotic disorders and polymorphisms in HT2A, DRD2, DRD4, SLC6A3 (DAT1), and BDNF: a family based association study. Am J Med Genet BNeuropsychiatr Genet 2004; 125: 69–78, [CROSSREF], [CSA]
- Furlong R A, Ho L, Rubinsztein J S, Walsh C, Paykel E S, Rubinsztein D C. Analysis of the monoamine oxidase A (MAOA) gene in bipolar affective disorder by association studies, meta-analyses, and sequencing of the promoter. Am J Med Genet 1999; 88: 398–406, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Preisig M, Bellivier F, Fenton B T, et al. Association between bipolar disorder and monoamine oxidase A gene polymorphisms: results of a multicenter study. Am J Psychiatry 2000; 157: 948–55, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Nothen M M, Eggermann K, Albus M, et al. Association analysis of the monoamine oxidase A gene in bipolar affective disorder by using family-based internal controls. Am J Hum Genet 1995; 57: 975–8, [PUBMED], [INFOTRIEVE], [CSA]
- Parsian A, Todd R D. Genetic association between monoamine oxidase and manic-depressive illness: comparison of relative risk and haplotype relative risk data. Am J Med Genet 1997; 74: 475–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Craddock N, Dave S, Greening J. Association studies of bipolar disorder. Bipolar Disord 2001; 3: 284–98, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mynett-Johnson L A, Murphy V E, Claffey E, Shields D C, McKeon P. Preliminary evidence of an association between bipolar disorder in females and the catechol-O-methyltransferase gene. Psychiatr Genet 1998; 8: 221–5, [PUBMED], [INFOTRIEVE], [CSA]
- Kirov G, Norton N, Jones I, McCandless F, Craddock N, Owen M J. A functional polymorphism in the promoter of monoamine oxidase A gene and bipolar affective disorder. Int J Neuropsychopharmcol 1999; 2: 293–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Geller B, Cook E H, Jr. Ultradian rapid cycling in prepubertal and early adolescent bipolarity is not in transmission disequilibrium with val/met COMT alleles. Biol Psychiatry 2000; 47: 605–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cho H J, Meira-Lima I, Cordeiro Q, et al. Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis. Mol Psychiatry 2005; 10: 771–81, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ho L W, Furlong R A, Rubinsztein J S, Walsh C, Paykel E S, Rubinsztein D C. Genetic associations with clinical characteristics in bipolar affective disorder and recurrent unipolar depressive disorder. Am J Med Genet 2000; 96: 36–42, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sklar P, Gabriel S B, McInnis M G, et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 2002; 7: 579–93, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Licinio J, Wong M L. Brain-derived neurotrophic factor (BDNF) in stress and affective disorders. Mol Psychiatry 2002; 7: 519, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy J L. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 2002; 71: 651–5, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Oswald P, Del-Favero J, Massat I, et al. Non-replication of the brain-derived neurotrophic factor (BDNF) association in bipolar affective disorder: a Belgian patient-control study. Am J Med Genet B Neuropsychiatr Genet 2004; 129: 34–5, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Nakata K, Ujike H, Sakai A, et al. Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci Lett 2003; 337: 17–20, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Geller B, Badner J A, Tillman R, Christian S L, Bolhofner K, Cook E H, Jr. Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2004; 161: 1698–700, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Neves-Pereira M, Cheung J K, Pasdar A, et al. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 2005; 10: 208–12, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chowdari K V, Mirnics K, Semwal P, et al. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 2002; 11: 1373–80, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Straub R E, Jiang Y, MacLean C J, et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002; 71: 337–48, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Stefansson H, Sigurdsson E, Steinthorsdottir V, et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71: 877–92, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chumakov I, Blumenfeld M, Guerassimenko O, et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A 2002; 99: 13675–80, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Craddock N, O'Donovan M C, Owen M J. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J Med Genet 2005; 42: 193–204, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Addington A M, Gornick M, Sporn A L, et al. Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified. Biol Psychiatry 2004; 55: 976–80, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Schumacher J, Jamra R A, Freudenberg J, et al. Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry 2004; 9: 203–7, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wang X, He G, Gu N, et al. Association of G72/G30 with schizophrenia in the Chinese population. Biochem Biophys Res Commun 2004; 319: 1281–6, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Korostishevsky M, Kaganovich M, Cholostoy A, et al. Is the G72/G30 locus associated with schizophrenia? single nucleotide polymorphisms, haplotypes, and gene expression analysis. Biol Psychiatry 2004; 56: 169–76, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zou F, Li C, Duan S, et al. A family-based study of the association between the G72/G30 genes and schizophrenia in the Chinese population. Schizophr Res 2005; 73: 257–61, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hattori E, Liu C, Badner J A, et al. Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. Am J Hum Genet 2003; 72: 1131–40, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chen Y S, Akula N, Detera-Wadleigh S D, et al. Findings in an independent sample support an association between bipolar affective disorder and the G72/G30 locus on chromosome 13q33. Mol Psychiatry 2004; 9: 87–92, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mulle J G, Chowdari K V, Nimgaonkar V, Chakravarti A. No evidence for association to the G72/G30 locus in an independent sample of schizophrenia families. Mol Psychiatry 2005; 10: 431–3, [PUBMED], [INFOTRIEVE], [CSA]
- Schulze T G, Ohlraun S, Czerski P M, et al. Genotype-phenotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: a first step toward a molecular genetic classification of psychiatric phenotypes. Am J Psychiatry 2005; 162: 2101–8, [PUBMED], [INFOTRIEVE], [CSA]
- Green E K, Raybould R, Macgregor S, et al. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Arch Gen Psychiatry 2005; 62: 642–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Raybould R, Green E K, Macgregor S, et al. Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1). Biol Psychiatry 2005; 57: 696–701, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Yamada M, Ohkawara B, Ichimura N, et al. Negative regulation of Wnt signalling by HMG2L1, a novel NLK-binding protein. Genes Cells 2003; 8: 677–84, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Klein P S, Melton D A. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A 1996; 93: 8455–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Obrien W T, Harper A D, Jove F, et al. Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium. J Neurosci 2004; 24: 6791–8, [CROSSREF], [CSA]
- Kang U G, Seo M S, Roh M S, Kim Y, Yoon S C, Kim Y S. The effects of clozapine on the GSK-3-mediated signaling pathway. FEBS Lett 2004; 560: 115–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Emamian E S, Hall D, Birnbaum M J, Karayiorgou M, Gogos J A. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 2004; 36: 131–7, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chen G, Huang L D, Jiang Y M, Manji H K. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J Neurochem 1999; 72: 1327–30, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Beaulieu J M, Sotnikova T D, Yao W D, et al. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci U S A 2004; 101: 5099–104, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Katsu T, Ujike H, Nakano T, et al. The human frizzled-3 (FZD3) gene on chromosome 8p21, a receptor gene for Wnt ligands, is associated with the susceptibility to schizophrenia. Neurosci Lett 2003; 353: 53–6, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Yang J, Si T, Ling Y, et al. Association study of the human FZD3 locus with schizophrenia. Biol Psychiatry 2003; 54: 1298–301, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zhang Y, Yu X, Yuan Y, et al. Positive association of the human frizzled 3 (FZD3) gene haplotype with schizophrenia in Chinese Han population. Am J Med Genet B Neuropsychiatr Genet 2004; 129: 16–9, [PUBMED], [INFOTRIEVE], [CSA]
- Toyota T, Yamada K, tera-Wadleigh S D, Yoshikawa T. Analysis of a cluster of polymorphisms in AKT1 gene in bipolar pedigrees: a family-based association study. Neurosci Lett 2003; 339: 5–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Benedetti F, Bernasconi A, Lorenzi C, et al. A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci Lett 2004; 355: 37–40, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Shprintzen R J, Goldberg R B, Lewin M L, et al. A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. Cleft Palate J 1978; 15: 56–62, [PUBMED], [INFOTRIEVE], [CSA]
- Shprintzen R J, Goldberg R, Golding-Kushner K J, Marion R W. Late-onset psychosis in the velo-cardio-facial syndrome. Am J Med Genet 1992; 42: 141–2, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Scambler P J, Kelly D, Lindsay E, et al. Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet 1992; 339: 1138–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Carlson C, Papolos D, Pandita R K, et al. Molecular analysis of velo-cardio-facial syndrome patients with psychiatric disorders. Am J Hum Genet 1997; 60: 851–9, [PUBMED], [INFOTRIEVE], [CSA]
- Murphy K C, Jones L A, Owen M J. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999; 56: 940–5, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Shifman S, Bronstein M, Sternfeld M, et al. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 2002; 71: 1296–302, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Glatt S J, Faraone S V, Tsuang M T. Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am J Psychiatry 2003; 160: 469–76, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Liu H, Heath S C, Sobin C, et al. Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc Natl Acad Sci U S A 2002; 99: 3717–22, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Williams H J, Williams N, Spurlock G, et al. Detailed analysis of PRODH and PsPRODH reveals no association with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2003; 120: 42–6, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mukai J, Liu H, Burt R A, et al. Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat Genet 2004; 36: 725–31, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- St Clair D, Blackwood D, Muir W, et al. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 1990; 336: 13–6, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Millar J K, Wilson-Annan J C, Anderson S, et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000; 9: 1415–23, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ozeki Y, Tomoda T, Kleiderlein J, et al. Disrupted-in-schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci U S A 2003; 100: 289–94, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Brandon N J, Handford E J, Schurov I, et al. Disrupted in schizophrenia 1 and nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders. Mol Cell Neurosci 2004; 25: 42–55, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hayashi M A, Portaro F C, Bastos M F, et al. Inhibition of NUDEL (nuclear distribution element-like)-oligopeptidase activity by disrupted-in-schizophrenia 1. Proc Natl Acad Sci U S A 2005; 102: 3828–33, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sawamura N, Sawamura-Yamamoto T, Ozeki Y, Ross C A, Sawa A. A form of DISC1 enriched in nucleus: altered subcellular distribution in orbitofrontal cortex in psychosis and substance/alcohol abuse. Proc Natl Acad Sci U S A 2005; 102: 1187–92, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hennah W, Varilo T, Kestila M, et al. Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum Mol Genet 2003; 12: 3151–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hodgkinson C A, Goldman D, Jaeger J, et al. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet 2004; 75: 862–72, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Devon R S, Anderson S, Teague P W, et al. Identification of polymorphisms within disrupted in schizophrenia 1 and disrupted in schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorder. Psychiatr Genet 2001; 11: 71–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Johnston N L, Cervenak J, Shore A D, Torrey E F, Yolken R H, Cerevnak J. Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. Stanley Neuropathology Consortium. J Neurosci Methods 1997; 77: 83–92, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Iwamoto K, Kakiuchi C, Bundo M, Ikeda K, Kato T. Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry 2004; 9: 406–16, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kato T, Iwayama Y, Kakiuchi C, et al. Gene expression and association analyses of LIM (PDLIM5) in bipolar disorder and schizophrenia. Mol Psychiatry 2005; 10: 1045–55, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tkachev D, Mimmack M L, Ryan M M, et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003; 362: 798–805, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Koh P O, Undie A S, Kabbani N, Levenson R, Goldman-Rakic P S, Lidow M S. Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients. Proc Natl Acad Sci U S A 2003; 100: 313–7, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Vawter M P, Thatcher L, Usen N, Hyde T M, Kleinman J E, Freed W J. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Mol Psychiatry 2002; 7: 571–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Guidotti A, Auta J, Davis J M, et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 2000; 57: 1061–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tremolizzo L, Carboni G, Ruzicka W B, et al. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc Natl Acad Sci U S A 2002; 99: 17095–100, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Veldic M, Guidotti A, Maloku E, Davis J M, Costa E. In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. Proc Natl Acad Sci U S A 2005; 102: 2152–7, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bjornsson H T, Fallin M D, Feinberg A P. An integrated epigenetic and genetic approach to common human disease. Trends Genet 2004; 20: 350–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Strasser H C, Lilyestrom J, Ashby E R, et al. Hippocampal and ventricular volumes in psychotic and nonpsychotic bipolar patients compared with schizophrenia patients and community control subjects: a pilot study. Biol Psychiatry 2005; 57: 633–9, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- McDonald C, Bullmore E T, Sham P C, et al. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry 2004; 61: 974–84, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chiaroni P, Hantouche E G, Gouvernet J, Azorin J M, Akiskal H S. The cyclothymic temperament in healthy controls and familially at risk individuals for mood disorder: endophenotype for genetic studies?. J Affect Disord 2005; 85: 135–45, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]